Pollak M - Search Results

1

Clinical development of inhibitors of the insulin-like growth factor receptor in oncology.

Gualberto A, Pollak M. Gualberto A, et al. Among authors: pollak m. Curr Drug Targets. 2009 Oct;10(10):923-36. doi: 10.2174/138945009789577945. Curr Drug Targets. 2009. PMID: 19663769 Review.

2

Insulin-like growth factor-related signaling and cancer development.

Pollak M. Pollak M. Recent Results Cancer Res. 2007;174:49-53. doi: 10.1007/978-3-540-37696-5_4. Recent Results Cancer Res. 2007. PMID: 17302184 Review.

3

Phase I, pharmacokinetic and pharmacodynamic study of the anti-insulinlike growth factor type 1 Receptor monoclonal antibody CP-751,871 in patients with multiple myeloma.

Lacy MQ, Alsina M, Fonseca R, Paccagnella ML, Melvin CL, Yin D, Sharma A, Enriquez Sarano M, Pollak M, Jagannath S, Richardson P, Gualberto A. Lacy MQ, et al. Among authors: pollak m. J Clin Oncol. 2008 Jul 1;26(19):3196-203. doi: 10.1200/JCO.2007.15.9319. Epub 2008 May 12. J Clin Oncol. 2008. PMID: 18474873 Clinical Trial.

4

The type 1 insulin-like growth factor receptor pathway.

Chitnis MM, Yuen JS, Protheroe AS, Pollak M, Macaulay VM. Chitnis MM, et al. Among authors: pollak m. Clin Cancer Res. 2008 Oct 15;14(20):6364-70. doi: 10.1158/1078-0432.CCR-07-4879. Clin Cancer Res. 2008. PMID: 18927274 Review.

5

Insulin receptor isoform A and insulin-like growth factor II as additional treatment targets in human osteosarcoma.

Avnet S, Sciacca L, Salerno M, Gancitano G, Cassarino MF, Longhi A, Zakikhani M, Carboni JM, Gottardis M, Giunti A, Pollak M, Vigneri R, Baldini N. Avnet S, et al. Among authors: pollak m. Cancer Res. 2009 Mar 15;69(6):2443-52. doi: 10.1158/0008-5472.CAN-08-2645. Epub 2009 Mar 3. Cancer Res. 2009. PMID: 19258511

6

Potential applications for biguanides in oncology.

Pollak M. Pollak M. J Clin Invest. 2013 Sep;123(9):3693-700. doi: 10.1172/JCI67232. Epub 2013 Sep 3. J Clin Invest. 2013. PMID: 23999444 Free PMC article. Review.

7

The insulin receptor/insulin-like growth factor receptor family as a therapeutic target in oncology.

Pollak M. Pollak M. Clin Cancer Res. 2012 Jan 1;18(1):40-50. doi: 10.1158/1078-0432.CCR-11-0998. Clin Cancer Res. 2012. PMID: 22215905

8

The insulin and insulin-like growth factor receptor family in neoplasia: an update.

Pollak M. Pollak M. Nat Rev Cancer. 2012 Feb 16;12(3):159-69. doi: 10.1038/nrc3215. Nat Rev Cancer. 2012. PMID: 22337149 Review.

9

Insulin-like growth factor receptor (IGF-1R) in breast cancer subtypes.

Yerushalmi R, Gelmon KA, Leung S, Gao D, Cheang M, Pollak M, Turashvili G, Gilks BC, Kennecke H. Yerushalmi R, et al. Among authors: pollak m. Breast Cancer Res Treat. 2012 Feb;132(1):131-42. doi: 10.1007/s10549-011-1529-8. Epub 2011 May 15. Breast Cancer Res Treat. 2012. PMID: 21574055

10

Insulin-like growth factor binding protein-2 is a novel therapeutic target associated with breast cancer.

So AI, Levitt RJ, Eigl B, Fazli L, Muramaki M, Leung S, Cheang MC, Nielsen TO, Gleave M, Pollak M. So AI, et al. Among authors: pollak m. Clin Cancer Res. 2008 Nov 1;14(21):6944-54. doi: 10.1158/1078-0432.CCR-08-0408. Clin Cancer Res. 2008. PMID: 18980989

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results